{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:36:15Z","timestamp":1791920175597,"version":"4.3.4"},"reference-count":40,"publisher":"Medical Association of Nippon Medical School","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nippon Med Sch"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1272\/jnms.84.125","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T22:14:03Z","timestamp":1500416043000},"page":"125-132","source":"Crossref","is-referenced-by-count":11,"title":["Metabolic and Inflammatory Changes with Orlistat and Sibutramine Treatment in Obese Malaysian Subjects"],"prefix":"10.1272","volume":"84","author":[{"given":"Belqes Abdullah Mohammad","family":"Al-Tahami","sequence":"first","affiliation":[{"name":"Pharmacology Vascular Laboratory, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ab Aziz","family":"Al-Safi Ismail","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulkefli","family":"Sanip","sequence":"additional","affiliation":[{"name":"Central Research Laboratory, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zurkurnai","family":"Yusoff","sequence":"additional","affiliation":[{"name":"Department of Medicine, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tg. Muzaffar TM","family":"Shihabudin","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taran Singh Pall","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida Hanum Ghulam","family":"Rasool","sequence":"additional","affiliation":[{"name":"Pharmacology Vascular Laboratory, School of Medical Sciences, Universiti Sains Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21","reference":[{"key":"1","unstructured":"1. World Health Organization: Noncommunicable diseases country profiles 2011, 2011; World Health Organization, Geneva (Switzerland)."},{"key":"2","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","volume":"366","author":"DW Haslam","year":"2005","unstructured":"2. Haslam DW, James WP: Obesity. Lancet 2005; 366: 1197-1209.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C, Coupaye M, Pelloux V, Hugol D, Bouillot JL, Bouloumi\u00e9 A, Barbatelli G, Cinti S, Svensson PA, Barsh GS, Zucker JD, Basdevant A, Langin D, Cl\u00e9ment K: Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.","DOI":"10.2337\/diabetes.54.8.2277"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Bluher M: Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 2009; 117: 241-250.","DOI":"10.1055\/s-0029-1192044"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Trayhurn P, Wood IS: Signaling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33: 1078-1081.","DOI":"10.1042\/BST0331078"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA: Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002; 51: 1884-1888.","DOI":"10.2337\/diabetes.51.6.1884"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Padwal RS, Majumdar SR: Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007; 369: 71-77.","DOI":"10.1016\/S0140-6736(07)60033-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Al-Tahami BA, Bee YT, Ismail AA, Rasool AH: Impaired microvascular endothelial function in relatively young obese humans is associated with altered metabolic and inflammatory markers. Clin Hemorheol Microcirc 2011; 47: 87-97.","DOI":"10.3233\/CH-2010-1370"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Al-Tahami BA, Ismail AA, Bee YT, Awang SA, Salha Wan Abdul Rani WR, Sanip Z, Rasool AH: The effects of anti-obesity intervention with orlistat and sibutramine on microvascular endothelial function. Clin Hemorheol Microcirc 2015; 59: 323-334.","DOI":"10.3233\/CH-131765"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Esler M, Strazniky N, Gikeli N, Masuo K, Lambert G, Lambert E: Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 2006; 48: 787-796.","DOI":"10.1161\/01.HYP.0000242642.42177.49"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Hall JE: The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633.","DOI":"10.1161\/01.HYP.0000052314.95497.78"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Goh VH, Tain CF, Tong TY, Mok HP, Wong MT: Are BMI and other anthropometric measures appropriate as indices for obesity? A study in an Asian population. J Lipid Res 2004; 45: 1892-1898.","DOI":"10.1194\/jlr.M400159-JLR200"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.","DOI":"10.1007\/BF00280883"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end stage renal disease. J Am Soc Nephrol 2002; 13: 1894-1900.","DOI":"10.1097\/01.ASN.0000019900.87535.43"},{"key":"15","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2009.04.010","volume":"58","author":"KA Varady","year":"2009","unstructured":"15. Varady KA, Tussing L, Bhutani S, Braunschweig CL: Degree of weight loss required to improve adipokine concentrations and decrease fat cell size in severely obese women. Metabolism 2009; 58: 1096-1101.","journal-title":"Metabolism Clinical and Experimental","ISSN":"https:\/\/id.crossref.org\/issn\/0026-0495","issn-type":"print"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Bougoulia M, Triantos A, Koliakos G: Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women. Hormones (Athens) 2006; 5: 259-269.","DOI":"10.14310\/horm.2002.11190"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kim DM, Yoon SJ, Ahn CW, Cha BS, Lim SK, Kim KR, Lee HC, Huh KB: Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women. Diabetes Res Clin Pract 2004; 66: S139-S144.","DOI":"10.1016\/j.diabres.2003.12.008"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Rucker D, Padwal R, Li SK, Curioni C, Lau DC: Long term pharmacotherapy for obesity and overweight: updated meta-analysis. BMJ 2007; 335: 1194-1199.","DOI":"10.1136\/bmj.39385.413113.25"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Derosa G, Cicero AFG, Murdolo G, Piccinni MN, Fogari E, Bertone G, Ciccarelli L, Fogari R: Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients. Diabetes Obes Metab 2005; 7: 47-55.","DOI":"10.1111\/j.1463-1326.2004.00372.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Hsieh CJ, Wang PW, Liu RT, Tung SC, Chien WY, Chen JF, Chen CH, Kuo MC, Hu YH: Orlistat for obesity: benefits beyond weight loss. Diabetes Res Clin Pract 2005; 67: 78-83.","DOI":"10.1016\/j.diabres.2004.05.012"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R: Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002; 290: 1084-1089.","DOI":"10.1006\/bbrc.2001.6307"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hu E, Liang P, Spiegelman BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703.","DOI":"10.1074\/jbc.271.18.10697"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126-1133.","DOI":"10.2337\/diabetes.50.5.1126"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7: 941-946.","DOI":"10.1038\/90984"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM: Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001; 86: 3815-3819.","DOI":"10.1210\/jcem.86.8.7741"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Xu A, Wang Y, Karen SLL: Adiponectin. In Adipose tissue and adipokines in health and disease (Fantuzzi G, Mazzone T, eds), 2007; pp 47-59, Humana Press, New Jersey.","DOI":"10.1007\/978-1-59745-370-7_4"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T: Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004; 89: 87-90.","DOI":"10.1210\/jc.2003-031163"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86: 1930-1935.","DOI":"10.1210\/jcem.86.5.7463"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sanip Z, Ariffin FD, Al-Tahami BA, Sulaiman WA, Rasool AH: Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females. Obes Res Clin Pract 2013; 7: e315-e320.","DOI":"10.1016\/j.orcp.2012.05.002"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L: Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 2001; 108: 1875-1881.","DOI":"10.1172\/JCI14120"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y: Diet-induced insulin resistance in mice lacking adiponectin\/ACRP30. Nat Med 2002; 8: 731-737.","DOI":"10.1038\/nm724"},{"key":"32","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.2337\/diabetes.52.6.1355","volume":"52","author":"X Wu","year":"2003","unstructured":"32. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ: Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes 2003; 52: 1355-1363.","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002; 8: 1288-1295.","DOI":"10.1038\/nm788"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Padwal R, Li SK, Lau DC: Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes Relat Metab Disord 2003; 27: 1437-1446.","DOI":"10.1038\/sj.ijo.0802475"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Valsamakis G, McTernan PG, Chetty R, Al Daghri N, Field A, Hanif W, Barnett AH, Kumar S: Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism 2004; 53: 430-434.","DOI":"10.1016\/j.metabol.2003.11.022"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.","DOI":"10.1161\/01.CIR.0000053730.47739.3C"},{"key":"37","unstructured":"37. Kobayashi S, Inoue N, Ohashi Y, Terashima M, Matsui K, Mori T, Fujita H, Awano K, Kobayashi K, Azumi H, Ejiri J, Hirata K, Kawashima S, Hayashi Y, Yokozaki H, Itoh H, Yokoyama M: Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler Thromb Vasc Biol 2003; 23: 1398-1404."},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV: Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 2004; 109: 3022-3028.","DOI":"10.1161\/01.CIR.0000130640.77501.79"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D: Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799-1804.","DOI":"10.1001\/jama.289.14.1799"},{"key":"40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5372\/1905-7415.0802.278","volume":"8","author":"FD Ariffin","year":"2014","unstructured":"40. Ariffin FD, Ismail A, Sean VTP, Yusoff Z, Awang SA, Rani WRWA, Rasool AHG: Improved insulin sensitivity, central systolic pressure and inflammatory indicators achieved with minor weight reduction in overweight and obese subjects given education on lifestyle modification. Asian Biomedicine 2014; 8: 185-194.","journal-title":"Asian Biomedicine","ISSN":"https:\/\/id.crossref.org\/issn\/1875-855X","issn-type":"print"}],"container-title":["Journal of Nippon Medical School"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/84\/3\/84_125\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T04:02:56Z","timestamp":1659240176000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnms\/84\/3\/84_125\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1272\/jnms.84.125","relation":{},"ISSN":["1345-4676","1347-3409"],"issn-type":[{"value":"1345-4676","type":"print"},{"value":"1347-3409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}